Biofrontera AG (B8F.DE) Stock Overview
Explore Biofrontera AG’s financial performance, market position, analyst ratings, and future outlook.
Biofrontera AG (B8F.DE)
Key Financials
Key Financials
Market Cap
20.7M
P/E Ratio
-1173.10
EPS (TTM)
$-0.21
ROE
-0.02%
B8F.DE Stock Analysis & Investment Overview (XETRA)
Our AI-powered analysis of Biofrontera AG (XETRA: B8F.DE) gives investors deep insight into how the stock performs on the XETRA exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Biofrontera AG's XETRA-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of B8F.DE on the XETRA shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the XETRA listing.
Key metrics behind Biofrontera AG's XETRA-traded stock include a P/E ratio of -1173.10 and a market capitalization of 20.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of B8F.DE on the XETRA.